| | T0 | T1 | p-value |
|---|
| 6MWD [m] | 496.5 ± 110.6 | 538.2 ± 111.1 | <.0001 |
|---|
| VC [l] (% predicted) | 3.54 ± 1.06 (86.6%) | 3.65 ± 1.05 (89.1%) | 0.2113 |
|---|
| FEV1[l] | 2.78 ± 0.89 (84.8%) | 3.02 ± 2.49 (86.8%) | 0.2003 |
|---|
| PI max [kPa] | 6.37 ± 3.31 (73.92%) | 7.21 ± 3.49 (87.6%) | 0.0003 |
|---|
| ACE [U/l] | 44.0 ± 28.5 | 41.8 ± 28.5 | 0.3090 |
|---|
| CRP [mg/l] | 3.6 ± 6.0 | 3.7 ± 7.1 | 0.3090 |
|---|
| SGRQ (symptoms) | 43.4 ± 24.6 | 35.5 ± 25.7 | 0.0007 |
|---|
| SGRQ (activity) | 49.0 ± 22.9 | 42.1 ± 25.2 | 0.0025 |
|---|
| SGRQ (impact) | 29.6 ± 20.3 | 25.0 ± 21.3 | 0.0122 |
|---|
| SGRQ (total score) | 38.2 ± 20.1 | 32.1 ± 21.7 | 0.0026 |
|---|
| SF 36 physical health | 30.8 ± 13.9 | 33.7 ± 18.1 | 0.0335 |
|---|
| SF 36 mental health | 27.9 ± 13.2 | 31.9 ± 17.3 | 0.0027 |
|---|
| FAS (Fatique Assessment Scale) | 2.7 ± 0.78 | 2.2 ± 0.73 | <.0001 |
|---|
| MMRC [Score 0 - 4] | 2.1 ± 1.3 | 1.8 ± 1.4 | <.0001 |
|---|